SCHEMBL8670004

SCHEMBL8670004

COc1ccc2nc(OCc3ccccc3)nc(NCc3ccc(C(O)O)cc3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.57
PDE5A O76074 2/20 0.54
TBXAS1 P24557 2/20 0.54
PDE3B Q13370 2/20 0.54
PDE3A Q14432 2/20 0.54
ERBB2 P04626 1/20 0.48
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
USP2 O75604 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
TSHR P16473 2/20 0.47
MAPK1 P28482 2/20 0.47
CYP2C19 P33261 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CLK4 Q9HAZ1 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498013 0.81 PDE5A (0.67) EGFRPDE5ATBXAS1PDE3BPDE3A
SCHEMBL2590386 0.77 EGFR (0.70) EGFRPDE5ATBXAS1PDE3BPDE3A
SCHEMBL21055800 0.75 EGFR (0.67) EGFRPDE5ATBXAS1PDE3BPDE3A
SCHEMBL7499766 0.74 ALDH1A1 (0.51) EGFRPDE5AERBB2ALDH1A1LMNA
SCHEMBL6471210 0.73 EGFR (0.50) EGFRERBB2ALDH1A1CYP1A2CYP3A4
SCHEMBL3118629 0.73 APP (0.68) EGFRALDH1A1LMNAUSP2CYP1A2
SCHEMBL7260498 0.73 CNR1 (0.54) PDE5ACNR1
SCHEMBL7505003 0.72 EGFR (0.71) EGFRPDE5AALDH1A1LMNAUSP2
SCHEMBL3118894 0.72 APP (0.74) EGFRALDH1A1LMNAUSP2CYP1A2
SCHEMBL3847323 0.71 EGFR (0.49) EGFRPDE5ATBXAS1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5801180-A ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS EISAI CO., LTD. (JP) 1998-09-01 US disclosed